Cite
HARVARD Citation
Tullman, M. et al. (2018). Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tullman, M. et al. (2018). Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS. Neurology. p. . [Online].